Evidence map›Paper›PMID 42512027›Full record

ArticleBiomedicines2026

Tirzepatide Attenuates Wire Injury-Induced Arterial Remodeling in Non-Diabetic and Diabetic Mice: Comparison with Semaglutide.

Yusaku Mori, Naoya Osaka, Michishige Terasaki, Hironori Yashima, Tomomi Saito, Daiki Tanno, Madoka Ogino, Makoto Ohara, Sho-Ichi Yamagishi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yusaku MoriDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.ORCID 0000-0002-1734-0605
Naoya OsakaDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
Michishige TerasakiDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
Hironori YashimaDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
Tomomi SaitoDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
Daiki TannoDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
Madoka OginoDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
Makoto OharaDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.
Sho-Ichi YamagishiDepartment of Diabetes, Metabolism, and Endocrinology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555, Japan.ORCID 0000-0003-0102-0823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arterial remodelingdiabetesdual GIP/GLP-1 receptor agonistGLP-1 receptor agonistnitric oxidevascular endothelial cells

Identifiers

PMID42512027
PMCPMC13405626

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.